About
John Kincaid is a biotechnology drug-discovery executive and medicinal chemist. He is Chief Scientific Officer at Aeovian Pharmaceuticals and previously served as a scientific founder and acting Head of Discovery at NFlection Therapeutics, while earlier founding Synterys and co-founding MyoTherix. This profile is for the biotech John Kincaid, not other public figures with the same name such as the Lafayette political scientist or the physician listed at Rapid Commercialization Partners.
Areas of interest
biotechdrug discoveryrare diseaseneuromuscular disordersneurofibromatosismTOR biologyage-related diseasesmedicinal chemistry